Cargando…
To evaluate the efficacy and safety of (125)I seed implantation in SCLC as second line therapy
This study aimed to evaluate the efficacy and safety of iodine 125 ((125)I) radioactive seed implantation for small cell lung cancer at the limited stage of relapse as second line therapy. We collected 6 patients with recurred limited stage small cell lung cancer, who got pathological diagnosis afte...
Autores principales: | Cheng, Guoli, Wang, Yizong, Dong, Dianguo, Zhang, Wenjie, Wang, Lei, Wan, Zhaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302288/ https://www.ncbi.nlm.nih.gov/pubmed/35866803 http://dx.doi.org/10.1097/MD.0000000000029251 |
Ejemplares similares
-
Efficacy and prognosis of surgery combined with (125)I seed implantation in treatment of recurrent glioma
por: Li, Weichang, et al.
Publicado: (2017) -
Oligorecurrence Non–small Cell Lung Cancer After Failure of First-Line Chemotherapy: Computed Tomography–Guided (125)I Seed Implantation vs. Second-Line Chemotherapy
por: Wang, Hao, et al.
Publicado: (2020) -
(125)I Radioactive Seeds Implantation Therapy for Hepatocellular Carcinoma
por: Lv, Jin, et al.
Publicado: (2009) -
MR‐guided 125I seed implantation treatment for maxillofacial malignant tumor
por: Wang, Ying, et al.
Publicado: (2020) -
The investigation of (125)I seed implantation as a salvage modality for unresectable pancreatic carcinoma
por: Wang, Hao, et al.
Publicado: (2013)